Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Cardiovasc J Afr ; 20(2): 122-5, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19421648

RESUMEN

OBJECTIVE: We investigated experimentally the in vivo prophylactic efficacies of linezolid, teicoplanin and vancomycin in subcutaneously implanted dacron graft infection caused by methicillin-resistant Staphylococcus aureus (MRSA). MATERIALS AND METHODS: Dacron grafts (1 cm(2)) were aseptically implanted into subcutaneous pockets that were surgically prepared in the backs of 50 rats. Ten of these rats were used as the control group (group I). Grafts in the remaining 40 rats were infected by inoculation of MRSA at the concentration of 2 x 10(7) colony-forming units (CFU)/ml. Ten of these rats constituted the contaminated, untreated group II. The other three study groups comprising 10 rats each were contaminated and then treated with linezolid (group III), teicoplanin (group IV) and vancomycin (group V), respectively. All rats were sacrificed and the grafts were removed after seven days and evaluated. RESULTS: The bacterial count decreased in the rats from the groups treated with linezolid, teicoplanin and vancomycin. The linezolid and teicoplanin groups, however, showed a significantly lower bacterial number than the vancomycin group (p = 0.009 and p = 0.01). The intensity of inflammation was highest in the contaminated, untreated group, as expected. CONCLUSIONS: Single-dose linezolid, teicoplanin and vancomycin for peri-operative prophylaxis may prevent bacterial growth in vascular graft infections. The effect of linezolid and teicoplanin seemed similar and their effect was greater than that of vancomycin.


Asunto(s)
Acetamidas/uso terapéutico , Profilaxis Antibiótica/métodos , Oxazolidinonas/uso terapéutico , Infecciones Relacionadas con Prótesis/prevención & control , Infecciones Estafilocócicas/prevención & control , Staphylococcus aureus/aislamiento & purificación , Teicoplanina/uso terapéutico , Vancomicina/uso terapéutico , Animales , Antiinfecciosos/uso terapéutico , Prótesis Vascular/microbiología , Modelos Animales de Enfermedad , Quimioterapia Combinada , Femenino , Linezolid , Resistencia a la Meticilina , Tereftalatos Polietilenos , Infecciones Relacionadas con Prótesis/microbiología , ARN Ribosómico 23S , Ratas , Ratas Wistar , Infecciones Estafilocócicas/microbiología , Staphylococcus aureus/patogenicidad , Resultado del Tratamiento
2.
Minerva Chir ; 62(3): 173-7, 2007 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-17519842

RESUMEN

AIM: We evauated the outcome of patients with left ventricular pseudoaneurysms, focusing on those treated surgically. METHODS: Between June 1990 and March 2007, 7 patients underwent surgery because of left ventricular pseudoaneursym following myocardial infarction, at our institution. The median time interval between myocardial infarction and the diagnosis of left ventricular psedoaneursym was 2.6 months (range: 15 days to 8 months). The aneursym was resected and the defect was closed with a Teflon patch or direct sutures. RESULTS: The location of the pseudoaneursym was posterior in 3 patients, inferolateral in 3 patients and anterolateral in 1 patient. The aneursym was resected and the defect was closed with a Teflon patch in 6 patients. In 1 patient with chronic pseudoaneurysm, the defect was closed with direct sutures reinforced with Teflon felt. In addition, 5 patients underwent coronary artery bypass grafting. The patients have been followed-up for a mean period of 45 months (range: 24 to 109 months). CONCLUSION: There was no intraoperative death. However, 2 patients died due to multiple organ failure, one 17 days and the other 1 month after the surgical operation. There was 1 late death due to the cancer. Currently, 1 patient is free of any cardiac symptoms, 2 patients have New York Heart Association (NYHA) Class II heart failure, and 1 patient with moderate mitral regurgitation is in class III.


Asunto(s)
Aneurisma Falso/cirugía , Aneurisma Cardíaco/cirugía , Ventrículos Cardíacos , Infarto del Miocardio/complicaciones , Anciano , Aneurisma Falso/etiología , Aneurisma Cardíaco/etiología , Humanos , Masculino , Persona de Mediana Edad
3.
Eur J Vasc Endovasc Surg ; 34(2): 182-7, 2007 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-17481929

RESUMEN

OBJECTIVES: Prophylactic efficiencies of cefazolin, teicoplanin and vancomycin in a dacron graft infection model caused by methicillin-susceptible (MSSA) or -resistant Staphylococcus aureus (MRSA) were investigated. DESIGN: Prospective, randomized, controlled animal study. MATERIALS AND METHODS: Infections were established subcutaneously in the back of rats by implantation of Dacron prostheses followed by topical inoculation onto grafts of MSSA or MRSA. Experimental groups were as follows: Uncontaminated group (control), MSSA- or MRSA-contaminated and untreated groups, MSSA- or MRSA-contaminated groups treated with cefazolin, teicoplanin or vancomycin by one of three regimens (one day, two days, or three days regimen). Grafts were removed 7 days after the implantation and evaluated by using sonication and quantitative blood agar culture. RESULTS: Contaminated groups demonstrated graft infections. Cefazolin, teicoplanin and vancomycin profoundly prevented the graft infections in MSSA- or MRSA-contaminated groups. For each antibiotic regimen, the most effective prevention was achieved by the drugs given as three days regimen. For MSSA and MRSA, the order of the effectiveness was as follows: teicoplanin>vancomycin>cefazolin. CONCLUSION: As a prophylactic agent, teicoplanin seems to be more effective than vancomycin and cefazolin against vascular graft infections caused by MSSA and MRSA in rats.


Asunto(s)
Antibacterianos/farmacología , Prótesis Vascular/efectos adversos , Cefazolina/farmacología , Infecciones Relacionadas con Prótesis/prevención & control , Infecciones Estafilocócicas/prevención & control , Staphylococcus aureus/efectos de los fármacos , Teicoplanina/farmacología , Vancomicina/farmacología , Animales , Antibacterianos/administración & dosificación , Antibacterianos/uso terapéutico , Cefazolina/administración & dosificación , Cefazolina/uso terapéutico , Recuento de Colonia Microbiana , Modelos Animales de Enfermedad , Esquema de Medicación , Masculino , Resistencia a la Meticilina , Tereftalatos Polietilenos , Diseño de Prótesis , Infecciones Relacionadas con Prótesis/microbiología , Ratas , Ratas Sprague-Dawley , Infecciones Estafilocócicas/microbiología , Staphylococcus aureus/aislamiento & purificación , Teicoplanina/administración & dosificación , Teicoplanina/uso terapéutico , Vancomicina/administración & dosificación , Vancomicina/uso terapéutico
4.
Eur J Vasc Endovasc Surg ; 31(3): 274-9, 2006 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-16360328

RESUMEN

OBJECTIVES: To compare the efficacy of a single prophylactic dose of intra-peritoneal vancomycin and teicoplanin with anti-biotic treated Dacron grafts (vancomycin, teicoplanin, 10 or 40% fusidic acid-soaked grafts) in preventing vascular graft infections in a rat model. DESIGN: Prospective, randomized, controlled animal study. MATERIALS AND METHODS: The graft infections were established in the subcutaneous tissues of 80 female Sprague-Dawley rats by the implantation of Dacron prostheses followed by the topical inoculation with methicillin-resistant Staphylococcus aureus. The study groups were as follows: (1) uncontaminated control group, (2) untreated contaminated group, (3) contaminated group with intra-peritoneal vancomycin, (4) contaminated group with intra-peritoneal teicoplanin, (5) contaminated group received vancomycin-soaked Dacron graft, (6) contaminated group received teicoplanin-soaked Dacron graft, (7) contaminated group received 40% fusidic acid-soaked Dacron graft, and (8) contaminated group received 10% fusidic acid-soaked Dacron graft prophylaxis. The grafts were removed after 7 days and evaluated by a quantitative culture analysis. RESULTS: No infection was detected in controls. The untreated contaminated group had a high bacteria count (6.0 x 10(4) CFU/cm2 Dacron graft). Groups that received intra-peritoneal vancomycin or teicoplanin had less bacterial growth (4.8 x 10(3) and 3.9 x 10(3)CFU/cm2 Dacron graft, respectively). Similarly, the group that received 10% fusidic acid-soaked graft showed less bacterial growth (3.6 x 10(3) CFU/cm2 Dacron graft). The groups with vancomycin-, teicoplanin- and 40% fusidic acid-soaked grafts showed no evidence of infection. Statistical analyses demonstrated that intra-peritoneal prophylactic antibiotic treatment was less effective in inhibiting bacterial growth than high concentration antimicrobial-soaking of grafts. CONCLUSION: The use of vancomycin-, teicoplanin- and 40% fusidic acid-soaked grafts was effective in preventing primary prosthetic vascular graft infection.


Asunto(s)
Antibacterianos/uso terapéutico , Profilaxis Antibiótica , Prótesis Vascular/efectos adversos , Ácido Fusídico/uso terapéutico , Infecciones Relacionadas con Prótesis/prevención & control , Teicoplanina/uso terapéutico , Vancomicina/uso terapéutico , Animales , Antibacterianos/administración & dosificación , Femenino , Ácido Fusídico/administración & dosificación , Infusiones Parenterales , Distribución Aleatoria , Ratas , Ratas Sprague-Dawley , Teicoplanina/administración & dosificación , Vancomicina/administración & dosificación
5.
Vasa ; 34(3): 195-7, 2005 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-16184840

RESUMEN

Anomalies of the ramification of arteries in the upper extremity are an important consideration due to the large number of invasive procedures, both diagnostic and therapeutic, performed particularly in the cubital region of the upper limb. It is important for health professionals to be aware of arterial variation to prevent complications during diagnostic and therapeutic procedures. Here, we describe a rare unilateral anomaly of the brachial artery which courses subcutaneously through the right arm to the cubital region in a 75 year-old female patient.


Asunto(s)
Artralgia/diagnóstico , Artralgia/etiología , Arteria Braquial/anomalías , Articulación de la Muñeca/irrigación sanguínea , Anciano , Femenino , Humanos
6.
Vasa ; 33(1): 46-8, 2004 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-15061048

RESUMEN

The incidence of arteriovenous fistulae (AVF) is quite rare in the head and neck region comprising less than 4% of all the traumatic AVF encountered elsewhere in the body. A 42-year-old man presented with a palpable thrill in the cervical region and headache. He had a shotgun injury 10 years ago and had no problem until the previous three months. Diagnosis of a high output traumatic AVF between right common carotid artery and internal jugular vein was made arteriographically. Presence of a neighbouring traumatic aneurysm on the common carotid artery and 9 mm diameter of the fistula tractus suggested open surgery. At the operation ligation of the tractus and aneurysmorraphy was performed and the patient was discharged in the third postoperative day. He has still no problem. This case documented that a shotgun injury even 10 years later may result with an AVF.


Asunto(s)
Aneurisma Falso/diagnóstico , Fístula Arteriovenosa/diagnóstico , Traumatismos de las Arterias Carótidas/diagnóstico , Venas Yugulares/lesiones , Traumatismos del Cuello/diagnóstico , Heridas por Arma de Fuego/diagnóstico , Adulto , Aneurisma Falso/cirugía , Angiografía , Fístula Arteriovenosa/cirugía , Traumatismos de las Arterias Carótidas/cirugía , Arteria Carótida Común/cirugía , Humanos , Venas Yugulares/cirugía , Masculino , Traumatismos del Cuello/cirugía , Técnicas de Sutura , Heridas por Arma de Fuego/cirugía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...